 ROCKVILLE, Md., Nov. 03, 2020 GLOBE NEWSWIRE -- Supernus Pharmaceuticals, Inc. Nasdaq: SUPN, a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system CNS diseases, today reported financial results for the third quarter of 2020 and associated Company developments. 